Select Publications

Journal articles

Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2024, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 83, pp. 350 - 359.e1, http://dx.doi.org/10.1053/j.ajkd.2023.07.023

Koshino A; Neuen BL; Oshima M; Toyama T; Hara A; Arnott C; Neal B; Jardine M; Badve SV; Mahaffey KW; Pollock C; Hansen MK; Wada T; Heerspink HJL, 2024, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial', Kidney International Reports, 9, pp. 347 - 355, http://dx.doi.org/10.1016/j.ekir.2023.11.024

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Bose B; Milanzi E; Pascoe EM; Johnson DW; Badve SV, 2023, 'The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0293721

Yeung WCG; Palmer SC; Strippoli GFM; Talbot B; Shah N; Hawley CM; Toussaint ND; Badve SV, 2023, 'Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 82, pp. 543 - 558, http://dx.doi.org/10.1053/j.ajkd.2023.04.003

Jun M; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; Mcarthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069

Amin S; Sangadi I; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Coulshed S; Foster S; Fernando M; Haloob I; Harris DCH; Hawley CM; Holt J; Howell M; Kumar K; Johnson DW; Lee VW; Mai J; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK, 2023, 'Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100691

Thomas MC; Neuen BL; Twigg SM; Cooper ME; Badve SV, 2023, 'SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review', Endocrine Connections, 12, http://dx.doi.org/10.1530/EC-23-0005

Inker LA; Collier W; Greene T; Miao S; Chaudhari J; Appel GB; Badve SV; Caravaca-Fontán F; Del Vecchio L; Floege J; Goicoechea M; Haaland B; Herrington WG; Imai E; Jafar TH; Lewis JB; Li PKT; Maes BD; Neuen BL; Perrone RD; Remuzzi G; Schena FP; Wanner C; Wetzels JFM; Woodward M; Heerspink HJL; Estacio RO; Hanratty R; Chalmers J; Canetta P; Barrett B; Neal B; Perkovic V; Mahaffey KW; Johnson D; Jardine M; von Eynatten M; Verde E; Verdalles U; Arroyo D; Chapman A; Torres V; Yu A; Brosnahan G; Hannedouche T; Chow KM; Szeto CC; Leung CB; Xie D; Hou FF; Dwyer J; Pohl MA; Raz I; Hunsicker LG; Vanacker A; Malfait T; Maschio G; Locatelli F; Blankestijn PJ; van Zuilen A; Kobayashi F; Makino H; Chan JCN; Andrulli S; Pozzi C; Casartelli D; Praga M; Trujillo H; Cavero T; Sevillano A; Ruggenenti P; Perna A; Carrara F; Keane WF; Manno C; Haynes R; Herrington WG; Baigent C; Landray M; Rauen T; Seikrit C; Wied S; Toto RD; de Jong PE; Saddelli M, 2023, 'A meta-analysis of GFR slope as a surrogate endpoint for kidney failure', Nature Medicine, 29, pp. 1867 - 1876, http://dx.doi.org/10.1038/s41591-023-02418-0

Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Lam D; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M, 2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675

Chung EYM; Badve SV; Heerspink HJL; Wong MG, 2023, 'Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?', Nephrology, 28, pp. 97 - 108, http://dx.doi.org/10.1111/nep.14130

Collier W; Inker LA; Haaland B; Appel GB; Badve SV; Caravaca-Fontán F; Chalmers J; Floege J; Goicoechea M; Imai E; Jafar TH; Lewis JB; Li PKT; Locatelli F; Maes BD; Neuen BL; Perrone RD; Remuzzi G; Schena FP; Wanner C; Heerspink HJL; Greene T, 2023, 'Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD', Clinical journal of the American Society of Nephrology : CJASN, 18, pp. 183 - 192, http://dx.doi.org/10.2215/CJN.0000000000000050

Madken M; Mallick R; Rhodes E; Mahdavi R; Bader Eddeen A; Hundemer GL; Kelly DM; Karaboyas A; Robinson B; Bieber B; Molnar AO; Badve SV; Tanuseputro P; Knoll G; Sood MM, 2023, 'Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD)', Canadian Journal of Kidney Health and Disease, 10, http://dx.doi.org/10.1177/20543581231169610

Hammett C; Badve SV; Kerr PG; Tran HA; Dundon BK; Lo S; Wong A; Joseph JE; Deague J; Perkovic V, 2022, 'Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice', Heart Lung and Circulation, 31, pp. 1604 - 1611, http://dx.doi.org/10.1016/j.hlc.2022.09.003

Viecelli AK; Teixeira-Pinto A; Valks A; Baer R; Cherian R; Cippà PE; Craig JC; DeSilva R; Jaure A; Johnson DW; Kiriwandeniya C; Kopperschmidt P; Liu WJ; Lee T; Lok C; Madhan K; Mallard AR; Oliver V; Polkinghorne KR; Quinn RR; Reidlinger D; Roberts M; Sautenet B; Hooi LS; Smith R; Snoeijs M; Tordoir J; Vachharajani TJ; Vanholder R; Vergara LA; Wilkie M; Yang B; Yuo TH; Zou L; Hawley CM; Robison L; Welch A; Badve SV; Boudville N; Campbell K; Cho Y; Collins M; Fahim MA; Jardine M; Du Toit D; Mayne M; Stevenson K; James R; Vu Q; Allen K; Glancy L; Kumbikkal J; Burton S; Gordon L; McCarthy K; Forrester C; Lima S; Bourgault O; Drouault C; Teasdale F; Jiun LW; Abidin J; Kiang CJ; Leng LS; Yusoff YM; Ciochina A; van Loon M; Ophelders R; Vleugels MJ; Ferrari P; Brodeur MÈ; Giunzioni D; Molfese CB; Blackwell C; Dunn L; Gillis L; Gray B; Jenkins S, 2022, 'Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID): A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice', BMC Nephrology, 23, http://dx.doi.org/10.1186/s12882-022-02987-1

Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, 24, pp. 1927 - 1938, http://dx.doi.org/10.1111/dom.14772

Ethier I; Boudville N; McDonald S; Brown F; Kerr PG; Walker R; Holt SG; Badve SV; Cho Y; Hawley C; Robison L; Reidlinger D; Milanzi E; Bieber B; McCullough K; Johnson DW, 2022, 'Representativeness of the PDOPPS cohort compared to the Australian PD population', Peritoneal Dialysis International, 42, pp. 403 - 414, http://dx.doi.org/10.1177/08968608211056242

Hockham C; Bao L; Tiku A; Badve SV; Bello AK; Jardine MJ; Jha V; Toyama T; Woodward M; Jun M, 2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030

Davies S; Zhao J; McCullough KP; Kim YL; Wang AYM; Badve SV; Mehrotra R; Kanjanabuch T; Kawanishi H; Robinson B; Pisoni R; Perl J, 2022, 'International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival', Kidney360, 3, pp. 872 - 882, http://dx.doi.org/10.34067/KID.0006922021

Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC, 2022, 'Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis', Journal of Nephrology, 35, pp. 1159 - 1170, http://dx.doi.org/10.1007/s40620-022-01268-2

Lioufas NM; Pascoe EM; Hawley CM; Elder GJ; Badve SV; Block GA; Johnson DW; Toussaint ND, 2022, 'Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD', Journal of the American Society of Nephrology, 33, pp. 59 - 76, http://dx.doi.org/10.1681/ASN.2021040554

Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA, 2022, 'Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region', Nephrology, 27, pp. 35 - 43, http://dx.doi.org/10.1111/nep.13953

Rangan GK; Wong ATY; Munt A; Zhang JQJ; Saravanabavan S; Louw S; Allman-Farinelli M; Badve SV; Boudville N; Chan J; Coolican H; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Gregory AV; Haloob I; Hawley CM; Holt J; Howard K; Howell M; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Pascoe E; Peduto A; Rangan A; Roger SD; Sherfan J; Sud K; Torres VE; Vilayur E; Harris DCH, 2022, 'Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease.', NEJM Evid, 1, pp. EVIDoa2100021, http://dx.doi.org/10.1056/EVIDoa2100021

Hultin S; Johnson DW; Badve SV, 2021, 'Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, 30, pp. 467 - 473, http://dx.doi.org/10.1097/MNH.0000000000000728

Badve SV, 2021, 'Editor's note', Internal Medicine Journal, 51, pp. 1368, http://dx.doi.org/10.1111/imj.15462

Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351

Tiku A; Johnson DW; Badve SV, 2021, 'Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, 30, pp. 346 - 352, http://dx.doi.org/10.1097/MNH.0000000000000699

Hultin S; Hood C; Campbell KL; Toussaint ND; Johnson DW; Badve SV, 2021, 'A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes', Kidney International Reports, 6, pp. 695 - 705, http://dx.doi.org/10.1016/j.ekir.2020.12.019

Conley M; Lioufas N; Toussaint ND; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Pedagogos E; Valks A; Campbell KL, 2021, 'Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease', Journal of Renal Nutrition, 31, pp. 155 - 163, http://dx.doi.org/10.1053/j.jrn.2020.02.007

O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281

Davies SJ; Zhao J; Morgenstern H; Zee J; Bieber B; Fuller DS; Sloand JA; Vychytil A; Kawanishi H; Johnson DW; Wang AYM; Kanjananbuch T; Boongird S; Moraes TP; Badve SV; Pisoni RL; Perl J, 2021, 'Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS', Kidney International Reports, 6, pp. 313 - 324, http://dx.doi.org/10.1016/j.ekir.2020.11.021

Palmer SC; Tendal B; Mustafa RA; Vandvik PO; Li S; Hao Q; Tunnicliffe D; Ruospo M; Natale P; Saglimbene V; Nicolucci A; Johnson DW; Tonelli M; Rossi MC; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque LI; Lloyd A; Ahmad N; Liu Y; Tiv S; Millard T; Gagliardi L; Kolanu N; Barmanray RD; McMorrow R; Raygoza Cortez AK; White H; Chen X; Zhou X; Liu J; Rodríguez AF; González-Colmenero AD; Wang Y; Li L; Sutanto S; Solis RC; Díaz González-Colmenero F; Rodriguez-Gutierrez R; Walsh M; Guyatt G; Strippoli GFM, 2021, 'Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials', The BMJ, 372, http://dx.doi.org/10.1136/bmj.m4573

CHENG L; Badve S; on behalf of the CKD-FIX Study Investigators, L , 2021, 'POS-311 POLYPHARMACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HIGH PROGRESSION RISK', Kidney International Reports, 6, pp. S134 - S134, http://dx.doi.org/10.1016/j.ekir.2021.03.327

Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM; Wyndham R; Vilayur E; Cooper B; Wong MG; Tan KS; van Eps C; Cho Y; Barbara J; Paizis K; McMahon LP; Nelson C; Gafor AHA; Meng OL; Mushahar L; Maher E, 2020, 'A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)', Journal of the American Society of Nephrology, 31, pp. 2653 - 2666, http://dx.doi.org/10.1681/ASN.2020040411

Wong ATY; Munt A; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Chandra AN; Coulshed S; Fernando M; Grantham J; Haloob I; Harris DCH; Hawley CM; Holt J; Johnson DW; Kumar K; Lee VW; Lonergan M; Mai J; Rangan A; Roger SD; Saravanabavan S; Sud K; Torres VE; Vilayur E; Zhang JQJ; Rangan GK, 2020, 'Assessment of dietary sodium intake using the scored salt questionnaire in autosomal dominant polycystic kidney disease', Nutrients, 12, pp. 1 - 14, http://dx.doi.org/10.3390/nu12113376

Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J, 2020, 'Effect of urate-lowering therapy on cardiovascular and kidney outcomes: A systematic review and meta-analysis', Clinical Journal of the American Society of Nephrology, 15, pp. 1576 - 1586, http://dx.doi.org/10.2215/CJN.05190420

Badve SV; Pascoe EM, 2020, 'Allopurinol and Chronic Kidney Disease. Reply', The New England journal of medicine, 383, pp. 1691 - 1692, http://dx.doi.org/10.1056/NEJMc2026125

Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM, 2020, 'Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants', American Journal of Kidney Diseases, 76, pp. 311 - 320, http://dx.doi.org/10.1053/j.ajkd.2020.02.446

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND, 2020, 'Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial', American Journal of Nephrology, 51, pp. 201 - 215, http://dx.doi.org/10.1159/000505717

Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K, 2020, 'Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry', Peritoneal Dialysis International, 40, pp. 209 - 219, http://dx.doi.org/10.1177/0896860819894058

Walsh M; Merkel PA; Peh C-A; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW, 2020, 'Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis', New England Journal of Medicine, 382, pp. 622 - 631, http://dx.doi.org/10.1056/nejmoa1803537

Chou A; Long C; Vonthethoff L; Ho SJ; Pettit F; Badve SV, 2020, 'Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery', Canadian Journal of Kidney Health and Disease, 7, http://dx.doi.org/10.1177/2054358120922629

Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; Chen JHC; Sypek M; Johnson DW, 2020, 'Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients', Peritoneal Dialysis International, 40, pp. 47 - 56, http://dx.doi.org/10.1177/0896860819879891

Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5

Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087

Boudville N; Ullah S; Clayton P; Sud K; Borlace M; Badve SV; Chakera A; Johnson DW, 2019, 'Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies', Nephrology Dialysis Transplantation, 34, pp. 1035 - 1044, http://dx.doi.org/10.1093/ndt/gfy340

Yeung WCG; Toussaint ND; Badve SV, 2019, 'Dual inhibition of gastrointestinal phosphate absorption: More questions than answers', Journal of the American Society of Nephrology, 30, pp. 909 - 910, http://dx.doi.org/10.1681/ASN.2019040333

Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', DIABETES, 68, http://dx.doi.org/10.2337/db19-1216-P


Back to profile page